Home » Topics » BioWorld Science

BioWorld Science
RSS

Methylation of MORC1 predicts depression risk in humans

Sep. 3, 2018

HDAC inhibition can help in DNA repair syndrome

Sep. 3, 2018

Cannabis-schizophrenia association goes both ways, but unequally

Sep. 3, 2018

How cirrhosis drug fights Alzheimer's disease

Sep. 3, 2018

Deleterious mutations in SQSTM1 cause early onset neurodegeneration

Sep. 3, 2018

EC approves Tafinlar + Mekinist for adjuvant treatment of BRAF V600 mutation-positive melanoma

Aug. 31, 2018

Cynata stem cell therapy meets safety and efficacy endpoints in phase I trial in GvHD

Aug. 31, 2018

Update on TULIP 1 phase III trial for anifrolumab in systemic lupus erythematosus

Aug. 31, 2018

MicroRNA-30c-5p identified as a potential therapeutic target and biomarker of neuropathic pain

Aug. 31, 2018

Computational analysis uncovers mechanisms to enhance the efficacy of anti-cancer immunotherapy

Aug. 31, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...